Earnings Feed
Start Free
Home/Filings/4/0001209191-15-047699
4//SEC Filing

PHARMACYCLICS INC 4

Accession 0001209191-15-047699

CIK 0000949699operating
View on SEC.govCompany Profile

Filed

May 27, 8:00 PM ET

Accepted

May 28, 6:57 PM ET

Size

68.6 KB

Accession

0001209191-15-047699

Insider Transaction Report

Form 4
Period: 2015-05-26
PHARMACYCLICS INCPCYC
van den Broek Richard
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−1,052→ 0 total
    Exercise: $28.47Exp: 2022-04-02→ Common Stock (1,052 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−546→ 0 total
    Exercise: $61.44Exp: 2023-01-02→ Common Stock (546 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−10,000→ 0 total
    Exercise: $2.90Exp: 2019-12-17→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,258→ 0 total
    Exercise: $3.10Exp: 2020-01-04→ Common Stock (7,258 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−510→ 0 total
    Exercise: $65.56Exp: 2022-10-01→ Common Stock (510 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $74.48Exp: 2023-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−374→ 0 total
    Exercise: $85.39Exp: 2023-07-01→ Common Stock (374 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−226→ 0 total
    Exercise: $139.89Exp: 2023-10-01→ Common Stock (226 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,555→ 0 total
    Exercise: $6.75Exp: 2020-07-01→ Common Stock (3,555 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−515→ 0 total
    Exercise: $59.28Exp: 2022-07-02→ Common Stock (515 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−4,140→ 0 total
    Exercise: $6.52Exp: 2021-01-03→ Common Stock (4,140 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−5,240→ 0 total
    Exercise: $6.01Exp: 2021-04-01→ Common Stock (5,240 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $5.76Exp: 2020-12-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−20,000→ 0 total
    Exercise: $5.81Exp: 2020-12-31→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $14.26Exp: 2021-12-15→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−456→ 0 total
    Exercise: $89.58Exp: 2024-07-01→ Common Stock (456 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−318→ 0 total
    Exercise: $124.46Exp: 2025-01-02→ Common Stock (318 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,976→ 0 total
    Exercise: $10.58Exp: 2021-07-01→ Common Stock (2,976 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,784→ 0 total
    Exercise: $11.31Exp: 2021-10-03→ Common Stock (2,784 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−264→ 0 total
    Exercise: $108.44Exp: 2024-01-02→ Common Stock (264 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,750→ 0 total
    Exercise: $95.08Exp: 2024-05-09→ Common Stock (3,750 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−338→ 0 total
    Exercise: $115.80Exp: 2024-10-01→ Common Stock (338 underlying)
  • Disposition from Tender

    Common Stock

    2015-05-26$261.25/sh−29,610$7,735,613→ 0 total(indirect: By LLC)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,619→ 0 total
    Exercise: $6.63Exp: 2020-04-01→ Common Stock (3,619 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−3,139→ 0 total
    Exercise: $8.12Exp: 2020-10-01→ Common Stock (3,139 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−2,409→ 0 total
    Exercise: $15.02Exp: 2022-01-03→ Common Stock (2,409 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−7,500→ 0 total
    Exercise: $49.00Exp: 2022-11-09→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−343→ 0 total
    Exercise: $79.67Exp: 2023-04-01→ Common Stock (343 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−280→ 0 total
    Exercise: $107.42Exp: 2024-04-01→ Common Stock (280 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2015-05-26−180→ 0 total
    Exercise: $257.01Exp: 2025-04-07→ Common Stock (180 underlying)
Footnotes (3)
  • [F1]Price reflects aggregate per share consideration paid pursuant to the Tender Offer.
  • [F2]Mr. van den Broek is the managing partner of HSMR Advisors, LLC.
  • [F3]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.

Documents

1 file

Issuer

PHARMACYCLICS INC

CIK 0000949699

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000949699

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:57 PM ET
Size
68.6 KB
View on SEC.gov